The Ma'Anshan Birth Cohort (MABC)
A Population-Based Prospective Cohort Study to Examine the Effects of Maternal Pregnancy Exposure on Adverse Pregnancy Outcomes, Child Health and Their Development.
1 other identifier
observational
3,474
1 country
1
Brief Summary
The Ma'anshan Birth Cohort (MABC) is a population-based prospective pregnancy and birth cohort study that aims to explore the early environmental and genetic determinants of maternal and child health, with a focus on health outcomes including maternal health, children's cognitive and behavioral development, growth and physical development, video-screen behaviors, and asthma and allergic diseases. MABC was officially launched in May 2013 at the Ma'anshan Maternal and Child Health Hospital in Anhui Province, and a total of 3,474 families were recruited as of September 2014 to continuously track the health status of mother-child pairs during pregnancy, delivery, and childhood, including basic family demographics, maternal pregnancy and birth history and past history, history of exposure to hazardous factors during pregnancy, children's diets and lifestyles, and children's physical and cognitive-behavioral development, MABC quantifies the attributional relationship between environmental chemicals, diet and nutrition, drug safety, psychological stress, lifestyle, biorhythm, endocrine metabolism and adverse birth outcomes, birth defects, neurodevelopmental disorders, developmental disabilities, etc., and identifies environmental, behavioral and genetic causative factors for birth defects and common developmental disorders, and identifies early warning signs and symptoms for early detection of birth defects. genetic causative factors, identify clinical biomarkers with early predictive effects, integrate and form a precise risk evaluation and early warning model, carry out regional comprehensive prevention and treatment applications, and promote the improvement of the quality of the birth population. Currently, MABC is conducting its 20th school-age follow-up visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2013
CompletedFirst Submitted
Initial submission to the registry
July 6, 2017
CompletedFirst Posted
Study publicly available on registry
July 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
April 12, 2024
April 1, 2024
14.6 years
July 6, 2017
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Numbers of participants with pregnancy complications
Including gestational diabetes, gestational hypertension, anemia, and hypothyroidism during pregnancy. Diagnosis by medical personnel at clinics
At delivery
Numbers of participants with adverse pregnancy outcomes
Including preterm birth, low birth weight, macrosomia, abortion, stillbirth, and birth defects. Hospital information system collection
At delivery
Secondary Outcomes (9)
Weight in kilogram changes during childhood
At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
Height in centimeter changes during childhood
At birth and age at 42 days, 3 months, 6 months, 9 months, 1 year, 1.5 years, 2 years, 2.5 years, 3 years, 3.5 years, 4 years, 4.5years, 5 years, 6 years, 7 years, 8 years, 9 years, 10 years, 11years and 12 years
Early Child development
Age at 6 months, 48 months and 54 months
Child Psychological and Behavioural Development
Age at 48 months, 60 months and 72 months
Child Intelligence quotient
At age of 54 months
- +4 more secondary outcomes
Eligibility Criteria
From May 2013 to September 2014, 3474 pregnant women who first established a maternal health handbook in Ma'anshan Maternal and Child Health Hospital (MCHH) and were willing to undergo regular obstetric checkups and deliveries in the hospital were selected for inclusion in the cohort.
You may qualify if:
- Permanent residents of Ma'anshan city;
- Obstetric examination and delivery at Ma'anshan Maternal and Child Health Hospital;
- Mother's age ≥ 18 years old and gestational week ≤ 14 weeks;
- No serious neuropsychiatric disorders, with sufficient understanding and expression to complete the survey.
You may not qualify if:
- Intellectual disability or other serious mental disorders;
- Suffering from serious underlying diseases and may have a significant impact on pregnancy outcome;
- Those with poor compliance and difficulty in follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ma'anshan Maternal and Child Health Care Hospital
Ma’anshan, Anhui, 243011, China
Biospecimen
Pregnancy and delivery:maternal blood, urine, cord blood and placenta. During infancy: urine and blood. During school age:Blood, urine and hair mother-child pairs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fangbiao Tao
Anhui Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 6, 2017
First Posted
July 12, 2017
Study Start
May 16, 2013
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
April 12, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share